Log In
Print
BCIQ
Print
Print this Print this
 

BHT-3034

  Manage Alerts
Collapse Summary General Information
Company Bayhill Therapeutics Inc.
DescriptionPlasmid encoding the extracellular domain of nicotinic acetylcholine receptor (nAchR) alpha 1
Molecular Target Nicotinic acetylcholine receptor (nAchR)
Mechanism of Action 
Latest Stage of DevelopmentPreclinical
IndicationMyasthenia gravis
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today